No evidence of substantia nigra telomere shortening in Parkinson's disease
Open accessThe DOI matches its Crossref record.
Abstract
Telomeres are repetitive tracts of DNA which protect chromosomal integrity. Increased oxidative stress leads to shorter telomeres, which have been associated with several late-onset human diseases. Given independent evidence of oxidative stress and Parkinson’s disease (PD), and conflicting reports of the role of telomere length in PD, we measured telomere length in both PD peripheral blood monocytes and in substantia nigra from affected individuals and controls. We confirmed previous findings of a paradoxically longer telomere length in blood from PD patients, but found no difference in telomere length in substantia nigra. Confounding factors provide a likely explanation for the findings in blood, and possibly the reduced frequency of cigarette smoking in PD patients. We conclude that telomere shortening is unlikely to be involved in the pathogenesis of PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Ageing as a Risk Factor for Disease
Niccoli, T., & Partridge, L. (2012) · Current Biology · doi:10.1016/j.cub.2012.07.024 · Cited by 1,831
“Telomere shortening seems to play no role in PD development [94] and, surprisingly, seems to be protective in AD [95].”
BackgroundIncreased epigenetic age and granulocyte counts in the blood of Parkinson's disease patients
Horvath, S., & Ritz, B. R. (2015) · Aging · doi:10.18632/aging.100859 · Cited by 436
Telomere shortening in neurological disorders: an abundance of unanswered questions
Eitan, E., Hutchison, E. R., & Mattson, M. P. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2014.02.010 · Cited by 158
Telomere length in Parkinson's disease: A meta-analysis
Forero, D. A., González-Giraldo, Y., López-Quintero, C., Castro-Vega, L. J., Barreto, G. E., & Perry, G. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.01.002 · Cited by 70
“Eight primary studies were included in the meta-analysis for PD and telomere length (Degerman et al., 2014; Eerola et al., 2010; Guan et al., 2008; Hudson et al., 2011; Schurks et al., 2014; Wang et al., 2008; Watfa et al., 2011).”
BackgroundResultInfluentialAge-Related Adaptive Immune Changes in Parkinson’s Disease
Kouli, A., & Williams-Gray, C. H. (2022) · Journal of Parkinson's Disease · doi:10.3233/jpd-223228 · Cited by 20
“, compared telomere lengths in peripheral blood mononuclear cells of 109 PD cases and 99 controls and reported significantly longer telomeres in PD patients versus controls, consistent with reduced leucocyte senescence [48].”
Result
Metadata
- Authors
- Hudson, G., Faini, D., Stutt, A., Eccles, M., Robinson, L., Burn, D. J., & Chinnery, P. F.
- Venue
- Neurobiology of Aging
- Publisher
- Elsevier BV
- Published
- 2011-11
- Volume
- 32
- Issue
- 11
- Pages
- 2107.e3-2107.e5
- ISSN
- 0197-4580 (ISSN-L)
- OpenAlex
- W2013237968
- Cited by
- 33
- References
- 0
- FWCI
- 1.65
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: No evidence of substantia nigra telomere shortening in Parkinson's disease. https://app.cochat.ai/papers/10.1016/j.neurobiolaging.2011.05.022
- The paper
- Hudson, G., Faini, D., Stutt, A., Eccles, M., Robinson, L., Burn, D. J., & Chinnery, P. F. (2011). No evidence of substantia nigra telomere shortening in Parkinson's disease. Neurobiology of Aging. https://doi.org/10.1016/j.neurobiolaging.2011.05.022
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.